• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

寻找受约束的 FTY720 和植物鞘氨醇类似物作为针对代谢和表观遗传途径的双重作用抗癌剂。

In search of constrained FTY720 and phytosphingosine analogs as dual acting anticancer agents targeting metabolic and epigenetic pathways.

机构信息

Department of Chemistry, Université de Montréal, PO Box 6128, Station Centre-Ville, Montréal, QC, H3C 3J7, Canada.

Department of Chemistry, Université de Montréal, PO Box 6128, Station Centre-Ville, Montréal, QC, H3C 3J7, Canada.

出版信息

Eur J Med Chem. 2018 Nov 5;159:217-242. doi: 10.1016/j.ejmech.2018.09.043. Epub 2018 Sep 21.

DOI:10.1016/j.ejmech.2018.09.043
PMID:30292898
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6217821/
Abstract

A series of compounds containing pyrrolidine and pyrrolizidine cores with appended hydrophobic substituents were prepared as constrained analogs of FTY720 and phytosphingosine. The effect of these compounds on the viability of cancer cells, on downregulation of the nutrient transport systems, and on their ability to cause vacuolation was studied. An attempt to inhibit HDACs with some phosphate esters of our analogs was thwarted by our failure to reproduce the reported inhibitory action of FTY720-phosphate.

摘要

我们制备了一系列含有吡咯烷和吡咯里西啶核心并带有附加疏水取代基的化合物,作为 FTY720 和植物鞘氨醇的刚性类似物。研究了这些化合物对癌细胞活力、营养物质转运系统下调以及引起空泡化能力的影响。我们试图用我们的类似物的一些磷酸盐来抑制 HDAC,但未能重现 FTY720-磷酸盐的报道抑制作用,这使我们的尝试受挫。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/35dd617cd7b3/nihms-1508910-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/9333aee5e325/nihms-1508910-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/e4841cad6f18/nihms-1508910-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/f96620150190/nihms-1508910-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/6e450fb5eedf/nihms-1508910-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/0a1f544404c0/nihms-1508910-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/2dfb79562a3e/nihms-1508910-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/3e448d25b76a/nihms-1508910-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/67fdf4aba83b/nihms-1508910-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/4a261a2d7f75/nihms-1508910-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/09a7e085f66d/nihms-1508910-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/35dd617cd7b3/nihms-1508910-f0012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/9333aee5e325/nihms-1508910-f0002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/e4841cad6f18/nihms-1508910-f0003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/f96620150190/nihms-1508910-f0004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/6e450fb5eedf/nihms-1508910-f0005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/0a1f544404c0/nihms-1508910-f0006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/2dfb79562a3e/nihms-1508910-f0007.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/3e448d25b76a/nihms-1508910-f0008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/67fdf4aba83b/nihms-1508910-f0009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/4a261a2d7f75/nihms-1508910-f0010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/09a7e085f66d/nihms-1508910-f0011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3264/6217821/35dd617cd7b3/nihms-1508910-f0012.jpg

相似文献

1
In search of constrained FTY720 and phytosphingosine analogs as dual acting anticancer agents targeting metabolic and epigenetic pathways.寻找受约束的 FTY720 和植物鞘氨醇类似物作为针对代谢和表观遗传途径的双重作用抗癌剂。
Eur J Med Chem. 2018 Nov 5;159:217-242. doi: 10.1016/j.ejmech.2018.09.043. Epub 2018 Sep 21.
2
Synthesis and Biological Evaluation of FTY720 (Fingolimod) Derivatives with Aromatic Head Group as Anticancer Agents.以芳香头基为抗癌剂的FTY720(芬戈莫德)衍生物的合成与生物学评价
Chem Pharm Bull (Tokyo). 2018;66(10):1015-1018. doi: 10.1248/cpb.c18-00065.
3
Synthesis of Novel FTY720 Analogs with Anticancer Activity through PP2A Activation.通过激活蛋白磷酸酶 2A(PP2A)合成具有抗癌活性的新型 FTY720 类似物。
Molecules. 2018 Oct 24;23(11):2750. doi: 10.3390/molecules23112750.
4
Synthesis and biological evaluation of 2-epi-jaspine B analogs as selective sphingosine kinase 1 inhibitors.2-表吉马烷 B 类似物的合成及生物评价作为选择性鞘氨醇激酶 1 抑制剂。
Bioorg Chem. 2020 May;98:103369. doi: 10.1016/j.bioorg.2019.103369. Epub 2019 Oct 17.
5
Identification of FTY720 and COH29 as novel topoisomerase I catalytic inhibitors by experimental and computational studies.通过实验和计算研究鉴定 FTY720 和 COH29 为新型拓扑异构酶 I 催化抑制剂。
Bioorg Chem. 2024 Jun;147:107412. doi: 10.1016/j.bioorg.2024.107412. Epub 2024 Apr 29.
6
Effects of phosphorylation of immunomodulatory agent FTY720 (fingolimod) on antiproliferative activity against breast and colon cancer cells.免疫调节剂FTY720(芬戈莫德)磷酸化对乳腺癌和结肠癌细胞抗增殖活性的影响。
Biol Pharm Bull. 2008 Jun;31(6):1177-81. doi: 10.1248/bpb.31.1177.
7
Synthetic analogs of FTY720 [2-amino-2-(2-[4-octylphenyl]ethyl)-1,3-propanediol] differentially regulate pulmonary vascular permeability in vivo and in vitro.FTY720 [2-氨基-2-(2-[4-辛基苯基]乙基)-1,3-丙二醇] 的合成类似物在体内和体外对肺血管通透性有不同的调节作用。
J Pharmacol Exp Ther. 2009 Oct;331(1):54-64. doi: 10.1124/jpet.109.153544. Epub 2009 Jul 10.
8
Genetic, biochemical, and transcriptional responses of Saccharomyces cerevisiae to the novel immunomodulator FTY720 largely mimic those of the natural sphingolipid phytosphingosine.酿酒酵母对新型免疫调节剂FTY720的遗传、生化和转录反应在很大程度上模拟了天然鞘脂植物鞘氨醇的反应。
J Biol Chem. 2004 Aug 27;279(35):36720-31. doi: 10.1074/jbc.M406179200. Epub 2004 Jun 9.
9
Antitumor effects of OSU-2S, a nonimmunosuppressive analogue of FTY720, in hepatocellular carcinoma.OSU-2S,一种 FTY720 的非免疫抑制类似物,在肝癌中的抗肿瘤作用。
Hepatology. 2011 Jun;53(6):1943-58. doi: 10.1002/hep.24293. Epub 2011 May 2.
10
Flexible, polymer-supported synthesis of sphingosine derivatives provides ceramides with enhanced biological activity.柔性的、聚合物负载的鞘氨醇衍生物合成方法可提供具有增强生物活性的神经酰胺。
Bioorg Med Chem. 2014 Oct 1;22(19):5506-12. doi: 10.1016/j.bmc.2014.07.024. Epub 2014 Jul 24.

引用本文的文献

1
Sphingosine simultaneously inhibits nuclear import and activates PP2A by binding importins and PPP2R1A.鞘氨醇通过结合输入蛋白和PPP2R1A同时抑制核输入并激活PP2A。
EMBO J. 2025 Jun 30. doi: 10.1038/s44318-025-00490-5.
2
Identification of Compounds with Potential Therapeutic Uses from Sweet Pepper ( L.) Fruits and Their Modulation by Nitric Oxide (NO).从甜椒(L.)果实中鉴定具有潜在治疗用途的化合物及其对一氧化氮(NO)的调节作用。
Int J Mol Sci. 2021 Apr 25;22(9):4476. doi: 10.3390/ijms22094476.
3
Design, synthesis and anticancer activity of constrained sphingolipid-phenoxazine/phenothiazine hybrid constructs targeting protein phosphatase 2A.设计、合成和抗癌活性的约束神经酰胺-吖啶/吩噻嗪杂合构建针对蛋白磷酸酶 2A。
Bioorg Med Chem Lett. 2019 Sep 15;29(18):2681-2685. doi: 10.1016/j.bmcl.2019.07.023. Epub 2019 Jul 19.

本文引用的文献

1
FTY720-induced endocytosis of yeast and human amino acid transporters is preceded by reduction of their inherent activity and TORC1 inhibition.FTY720 诱导酵母和人氨基酸转运蛋白的内吞作用是在降低其固有活性和 TORC1 抑制之前发生的。
Sci Rep. 2017 Oct 23;7(1):13816. doi: 10.1038/s41598-017-14124-2.
2
Targeting Metabolism for Cancer Therapy.靶向代谢治疗癌症。
Cell Chem Biol. 2017 Sep 21;24(9):1161-1180. doi: 10.1016/j.chembiol.2017.08.028.
3
New drugs, new toxicities: severe side effects of modern targeted and immunotherapy of cancer and their management.新药,新毒性:癌症现代靶向治疗和免疫治疗的严重副作用及其管理
Crit Care. 2017 Apr 14;21(1):89. doi: 10.1186/s13054-017-1678-1.
4
Targeting cancer metabolism by simultaneously disrupting parallel nutrient access pathways.通过同时破坏平行的营养物质获取途径来靶向癌症代谢。
J Clin Invest. 2016 Nov 1;126(11):4088-4102. doi: 10.1172/JCI87148. Epub 2016 Sep 26.
5
Medicinal Chemistry Projects Requiring Imaginative Structure-Based Drug Design Methods.需要富有创意的基于结构的药物设计方法的药物化学项目。
Acc Chem Res. 2016 Sep 20;49(9):1646-57. doi: 10.1021/acs.accounts.6b00185. Epub 2016 Aug 16.
6
Effects of stereochemistry, saturation, and hydrocarbon chain length on the ability of synthetic constrained azacyclic sphingolipids to trigger nutrient transporter down-regulation, vacuolation, and cell death.立体化学、饱和度和烃链长度对合成的受限氮杂环鞘脂触发营养转运体下调、空泡化和细胞死亡能力的影响。
Bioorg Med Chem. 2016 Sep 15;24(18):4390-4397. doi: 10.1016/j.bmc.2016.07.038. Epub 2016 Jul 18.
7
Cancer metabolism: a therapeutic perspective.癌症代谢:治疗新视角
Nat Rev Clin Oncol. 2017 Jan;14(1):11-31. doi: 10.1038/nrclinonc.2016.60. Epub 2016 May 4.
8
Synthesis, identification, and biological activity of metabolites of two novel selective S1P1 agonists.两种新型选择性S1P1激动剂代谢产物的合成、鉴定及生物活性
Bioorg Med Chem. 2016 May 15;24(10):2273-9. doi: 10.1016/j.bmc.2016.03.059. Epub 2016 Mar 31.
9
Attacking the supply wagons to starve cancer cells to death.攻击补给车以饿死癌细胞。
FEBS Lett. 2016 Apr;590(7):885-907. doi: 10.1002/1873-3468.12121. Epub 2016 Mar 22.
10
Elevated Nuclear and Cytoplasmic FTY720-Phosphate in Mouse Embryonic Fibroblasts Suggests the Potential for Multiple Mechanisms in FTY720-Induced Neural Tube Defects.小鼠胚胎成纤维细胞中细胞核和细胞质内磷酸化FTY720水平升高表明FTY720诱导神经管缺陷存在多种机制的可能性。
Toxicol Sci. 2016 Mar;150(1):161-8. doi: 10.1093/toxsci/kfv321. Epub 2015 Dec 29.